Scientific Poster Download

Next-generation ADCs and novel bioconjugate modalities pose unprecedented formulation and delivery challenges that require tailored and manufacturable drug product development strategies.

 
In this scientific poster, we present WuXi XDC’s integrated, target product profile-driven strategy to address the emerging formulation challenges of next-generation ADCs and new bioconjugate modalities. Supported by interconnected capabilities in high-throughput screening, pre-formulation screening, photosensitivity control, advanced lyophilization, and large-volume subcutaneous delivery, this molecule-to-product approach enables robust, deliverable, and manufacturable drug product solutions for next-generation ADCs and new modalities.